89
Views
9
CrossRef citations to date
0
Altmetric
Original Research

LncRNA SNHG17 Contributes to the Progression of Cervical Cancer by Targeting microRNA-375-3p

, &
Pages 4969-4978 | Published online: 23 Jun 2021

References

  • Fowler JR, Jack BW. Cervical Cancer. StatPearls. StatPearls Publishing. Copyright © 2020, StatPearls Publishing LLC; 2020.
  • Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. Lancet. 2019;393(10167):169–182. doi:10.1016/S0140-6736(18)32470-X30638582
  • Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–e203. doi:10.1016/S2214-109X(19)30482-631812369
  • Salunkhe R, Chopra S, Kulkarni S, et al. Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: an institutional audit. Indian J Cancer. 2020;57(4):416–422. doi:10.4103/ijc.IJC_704_1833078748
  • Tsikouras P, Zervoudis S, Manav B, et al. Cervical cancer: screening, diagnosis and staging. J buon. 2016;21(2):320–325.27273940
  • Ngo-Metzger Q, Adsul P. Screening for cervical cancer. Am Fam Physician. 2019;99(4):253–254.30763054
  • Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22–36. doi:10.1038/s41568-020-00306-033082563
  • Yarmishyn AA, Kurochkin IV. Long noncoding RNAs: a potential novel class of cancer biomarkers. Front Genet. 2015;6:145. doi:10.3389/fgene.2015.0014525954300
  • Yang B, Zhang L, Cao Y, et al. Overexpression of lncRNA IGFBP4–1 reprograms energy metabolism to promote lung cancer progression. Mol Cancer. 2017;16(1):154. doi:10.1186/s12943-017-0722-828946875
  • Shima H, Kida K, Adachi S, et al. Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness. Breast Cancer Res Treat. 2018;170(3):507–516. doi:10.1007/s10549-018-4793-z29693231
  • Li Q-G, Xu X-Q, Zhou D-Y, et al. Long non-coding RNA DILC as a potentially useful biomarker for the diagnosis and prognosis of colorectal cancer. Eur Rev Med Pharmacol Sci. 2019;23(8):3320–3325. doi:10.26355/eurrev_201904_1769431081085
  • Mahmoudian-Sani M-R, Jalali A, Jamshidi M, et al. Long non-coding RNAs in thyroid cancer: implications for pathogenesis, diagnosis, and therapy. Oncol Res Treat. 2019;42(3):136–142. doi:10.1159/00049515130799425
  • Pan X, Guo Z, Chen Y, et al. STAT3-induced lncRNA SNHG17 exerts oncogenic effects on ovarian cancer through regulating CDK6. Mol Ther Nucleic Acids. 2020;22:38–49. doi:10.1016/j.omtn.2020.08.00632911343
  • Tong F, Guo J, Miao Z, Li Z. LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis. Cancer Biomark. 2021;30(1):1–12. doi:10.3233/CBM-19107032924983
  • Li W, Zheng Y, Mao B, Wang F, Zhong Y, Cheng D. SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485–5p. Biochem Biophys Res Commun. 2020;533(4):1435–1441. doi:10.1016/j.bbrc.2020.09.13033109341
  • Xu T, Yan S, Jiang L, et al. Gene amplification-driven long noncoding RNA SNHG17 regulates cell proliferation and migration in human non-small-cell lung cancer. Mol Ther Nucleic Acids. 2019;17:405–413. doi:10.1016/j.omtn.2019.06.00831310946
  • Du F, Hou Q. SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis. BMC Cancer. 2020;20(1):839. doi:10.1186/s12885-020-07280-832883232
  • Liu J, Zhan Y, Wang J, Wang J, Guo J, Kong D. lncRNA-SNHG17 promotes colon adenocarcinoma progression and serves as a sponge for miR-375 to regulate CBX3 expression. Am J Transl Res. 2020;12(9):5283–5295.33042419
  • Babion I, Snoek BC, Novianti PW, et al. Triage of high-risk HPV-positive women in population-based screening by miRNA expression analysis in cervical scrapes; a feasibility study. Clin Epigenetics. 2018;10(1):76. doi:10.1186/s13148-018-0509-929930741
  • Ma Z, Gu S, Song M, et al. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer. Mol Biosyst. 2017;13(11):2350–2361. doi:10.1039/C7MB00280G28933484
  • Wu Y, Sun X, Song B, Qiu X, Zhao J. MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion. Cancer Med. 2017;6(7):1686–1697. doi:10.1002/cam4.111028627030
  • Jules J, Maiguel D, Hudson BI, Oury TD. Alternative splicing of the RAGE cytoplasmic domain regulates cell signaling and function. PLoS One. 2013;8(11):e78267. doi:10.1371/journal.pone.007826724260107
  • van de Merbel AF, van der Horst G, Buijs JT, van der Pluijm G. Protocols for migration and invasion studies in prostate cancer. Methods Mol Biol. 1786;67–79.
  • McGuire A, Brown JAL, Kerin MJ. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Rev. 2015;34(1):145–155. doi:10.1007/s10555-015-9551-725721950
  • Solé C, Moliné T, Vidal M, Ordi-Ros J, Cortés-Hernández J. An exosomal urinary miRNA signature for early diagnosis of renal fibrosis in lupus nephritis. Cells. 2019;8(8). doi:10.3390/cells8080773
  • Tutar Y. Editorial (Thematic issue: “miRNA and cancer; computational and experimental approaches”). Curr Pharm Biotechnol. 2014;15(5):429. doi:10.2174/13892010150514082816133525189575
  • Mishra PK, Nemer G. Editorial: the non-coding genome and cardiovascular disease. Front Cardiovasc Med. 2019;6:98. doi:10.3389/fcvm.2019.0009831380396
  • Yao Z, Jia C, Tai Y, et al. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma. Aging. 2020;12(12):11843–11863. doi:10.18632/aging.10335532554864
  • Liu L, Shuai T, Li B, Zhu L, Li X. Long non-coding RNA lnc-GNAT1-1 inhibits gastric cancer cell proliferation and invasion through the Wnt/β-catenin pathway in Helicobacter pylori infection. Mol Med Rep. 2018;18(4):4009–4015. doi:10.3892/mmr.2018.940530132541
  • Chen -L-L, He J, Qiu X-T, Yu J, Wang Z-M. The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23(3):1063–1068. doi:10.26355/eurrev_201902_1699430779073
  • Liu Y, Li Q, Tang D, et al. SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis. Cancer Cell Int. 2020;20(1):566. doi:10.1186/s12935-020-01621-033292246
  • Wu G, Hao C, Qi X, et al. LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop. Cell Death Dis. 2020;11(5):393. doi:10.1038/s41419-020-2569-y32447342
  • Du Y, Wei N, Hong J, Pan W. Long non-coding RNASNHG17 promotes the progression of breast cancer by sponging miR-124-3p. Cancer Cell Int. 2020;20(1):40. doi:10.1186/s12935-020-1129-y32042267
  • Zheng Z-J, Liu Y, Wang H-J, Pang -W-W, Wang Y. LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1. Eur Rev Med Pharmacol Sci. 2020;24(18):9282–9289. doi:10.26355/eurrev_202009_2301033015769
  • Yu X, Zhao W, Yang X, Wang Z, Hao M. miR-375 affects the proliferation, invasion, and apoptosis of HPV16-positive human cervical cancer cells by targeting IGF-1R. Int J Gynecol Cancer. 2016;26(5):851–858. doi:10.1097/IGC.000000000000071127206217
  • Kim J, Abdelmohsen K, Yang X, et al. LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR. Nucleic Acids Res. 2016;44(5):2378–2392. doi:10.1093/nar/gkw01726819413